Second, systemic CXCL5 suppression improved the blood flow recovery after hindlimb ischemia surgery, increased the number of EPCs in circulation, and upregulated VEGF and SDF-1 expressions in the ischemic gastrocnemius muscle in DM mice. Here, CXCL12 is linked to diabetes mellitus.